Pharmacokinetic Effects of Coadministration of Lersivirine with Raltegravir or Maraviroc in Healthy Subjects

類似資料

• Lack of a Clinically Relevant Effect of an Antacid on the Pharmacokinetics of Lersivirine
  著者:: Vourvahis, M., 等
  出版事項: (2010)
• Effects of ketoconazole and valproic acid on the pharmacokinetics of the next generation NNRTI, lersivirine (UK-453,061), in healthy adult subjects
  著者:: Langdon, Grant, 等
  出版事項: (2012)
• Effect of Rifampin and Rifabutin on the Pharmacokinetics of Lersivirine and Effect of Lersivirine on the Pharmacokinetics of Rifabutin and 25-O-Desacetyl-Rifabutin in Healthy Subjects
  著者:: Vourvahis, Manoli, 等
  出版事項: (2012)
• Pharmacokinetic Interaction between Maraviroc and Fosamprenavir-Ritonavir: an Open-Label, Fixed-Sequence Study in Healthy Subjects
  著者:: Vourvahis, Manoli, 等
  出版事項: (2013)
• No Effect of a Single Supratherapeutic Dose of Lersivirine, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor, on Corrected QT Interval in Healthy Subjects
  著者:: Vourvahis, Manoli, 等
  出版事項: (2012)